KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Long-Term Deferred Tax (2016 - 2025)

Historic Long-Term Deferred Tax for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $5.4 billion.

  • Novartis Ag's Long-Term Deferred Tax rose 2475.34% to $5.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.4 billion, marking a year-over-year increase of 2475.34%. This contributed to the annual value of $5.4 billion for FY2025, which is 2475.34% up from last year.
  • Latest data reveals that Novartis Ag reported Long-Term Deferred Tax of $5.4 billion as of Q4 2025, which was up 2475.34% from $5.6 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Long-Term Deferred Tax registered a high of $8.1 billion during Q2 2021, and its lowest value of $12.0 million during Q1 2021.
  • In the last 5 years, Novartis Ag's Long-Term Deferred Tax had a median value of $4.2 billion in 2023 and averaged $4.1 billion.
  • Per our database at Business Quant, Novartis Ag's Long-Term Deferred Tax plummeted by 9741.38% in 2021 and then soared by 790196.08% in 2023.
  • Novartis Ag's Long-Term Deferred Tax (Quarter) stood at $3.7 billion in 2021, then fell by 0.11% to $3.7 billion in 2022, then increased by 15.24% to $4.3 billion in 2023, then grew by 1.16% to $4.4 billion in 2024, then rose by 24.75% to $5.4 billion in 2025.
  • Its last three reported values are $5.4 billion in Q4 2025, $5.6 billion for Q3 2025, and $5.2 billion during Q2 2025.